3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
110
Carcinoma, Intraductal, Noninfiltrating
7
Breast Carcinoma In Situ
6
Neoplasms
4
Neoplasm Metastasis
3
Inflammatory Breast Neoplasms
3
Carcinoma, Ductal, Breast
3
Breast Neoplasms, Male
3
Infertility
2
Fallopian Tube Neoplasms
2
Endometrial Neoplasms
2
Breast Cancer Female
2
Sleep Wake Disorders
1
Quality of Life
1
Pulmonary Fibrosis
1
Prostatic Neoplasms
1
Primary Breast Cancer
1
Polycystic Ovary Syndrome
1
Paget's Disease, Mammary
1
Ovarian Neoplasms
1
Obesity
1
Neoplasm Recurrence, Local
1
Liver Neoplasms
1
Hot Flashes
1
Fatigue
1
Cardiotoxicity
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Lobular
1
Carcinoma, Hepatocellular
1
Breast Cancer Subjects
1
Interventions
Metformin
21
Letrozole
11
Clomiphene
7
dapagliflozin
4
Contraceptives, Oral
4
Chorionic Gonadotropin
4
cetrorelix
3
Liraglutide
3
Inositol
3
follitropin beta
2
follitropin alfa
2
drospirenone and ethinyl estradiol combination
2
Musculoskeletal Manipulations
2
Glycoprotein Hormones, alpha Subunit
2
DLBS3233
2
Cholecalciferol
2
semaglutide
1
saxagliptin
1
lime
1
follicle stimulating hormone, human, with HCG C-terminal peptide
1
drospirenone
1
cinnulin PF
1
Urofollitropin
1
Triptorelin Pamoate
1
Treatment Expectations
1
Thioctic Acid
1
Tamoxifen
1
Tablets
1
Sugars
1
Sperm Injections, Intracytoplasmic
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Polycystic Ovary Syndrome
×
Tamoxifen
×
Clear all
NCT07616973
2026-06-01
LET-CC-TAM
Sana'a University
Phase 3
Active not recruiting
240 enrolled